Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.

Saved in:
Bibliographic Details
Title: Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Authors: Juan-Giner A; Epicentre, Paris, France., Kimathi D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grantz KH; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Hamaluba M; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Kazooba P; Epicentre Mbarara Research Centre, Mbarara, Uganda., Njuguna P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Fall G; Institut Pasteur Dakar, Dakar, Senegal., Dia M; Institut Pasteur Dakar, Dakar, Senegal., Bob NS; Institut Pasteur Dakar, Dakar, Senegal., Monath TP; Crozet BioPharma LLC, Devens, MA, USA., Barrett AD; Sealy Institute for Vaccines Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Hombach J; Immunization, Vaccines & Biologicals, WHO, Geneva, Switzerland., Mulogo EM; Department of Community Health, Mbarara University of Science & Technology, Mbarara, Uganda., Ampeire I; Expanded Program on Immunization, Ministry of Health, Kampala, Uganda., Karanja HK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Nyehangane D; Epicentre Mbarara Research Centre, Mbarara, Uganda., Mwanga-Amumpaire J; Epicentre Mbarara Research Centre, Mbarara, Uganda., Cummings DAT; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA., Bejon P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Warimwe GM; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grais RF; Epicentre, Paris, France. Electronic address: rebecca.grais@epicentre.msf.org.
Source: Lancet (London, England) [Lancet] 2021 Jan 09; Vol. 397 (10269), pp. 119-127.
Publication Type: Equivalence Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first